Wells Fargo’s Mereo BioPharma MREO Stock Holding History

Wells Fargo’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73	Buy	231 +1	+0.4%	–	﹤0.01%	6679
2026 Q1	$76	Sell	230 -1,507	-87%	-$647	﹤0.01%	6536
2025 Q4	$724	Buy	1,737 +1,507	+655%	+$2.87K	﹤0.01%	6309
2025 Q3	$473	Hold	230	–	–	﹤0.01%	6297
2025 Q2	$622	Sell	230 -1,000	-81%	-$2.41K	﹤0.01%	6355
2025 Q1	$2.77K	Buy	1,230 +1,001	+437%	+$2.83K	﹤0.01%	6116
2024 Q4	$802	Sell	229 -1	-0.4%	-$4	﹤0.01%	6279
2024 Q3	$943	Hold	230	–	–	﹤0.01%	6130
2024 Q2	$826	Hold	230	–	–	﹤0.01%	6111
2024 Q1	$757	Hold	230	–	–	﹤0.01%	6215
2023 Q4	$530	Hold	230	–	–	﹤0.01%	6370
2023 Q3	$296	Sell	230 -5,000	-96%	-$6.63K	﹤0.01%	6482
2023 Q2	$6.9K	Buy	5,230 +5,001	+2,184%	+$5.8K	﹤0.01%	6009
2023 Q1	$162	Sell	229 -1	-0.4%	-$1	﹤0.01%	6830
2022 Q4	$173	Sell	230 -500	-68%	-$411	﹤0.01%	6659
2022 Q3	$0	Buy	730 +500	+217%	+$612	﹤0.01%	7103
2022 Q2	$0	Hold	230	–	–	﹤0.01%	7235
2022 Q1	$0	Hold	230	–	–	﹤0.01%	7540
2021 Q4	$0	Sell	230 -3,000	-93%	-$6K	﹤0.01%	7595
2021 Q3	$8K	Hold	3,230	–	–	﹤0.01%	6275
2021 Q2	$10K	Hold	3,230	–	–	﹤0.01%	6143
2021 Q1	$11K	Buy	3,230 +3,000	+1,304%	+$10.6K	﹤0.01%	6320
2020 Q4	$1K	Hold	230	–	–	﹤0.01%	6362
2020 Q3	$1K	Buy	230 +1	+0.4%	+$3	﹤0.01%	6219
2020 Q2	$1K	Hold	229	–	–	﹤0.01%	6179
2020 Q1	$0	Hold	229	–	–	﹤0.01%	6578
2019 Q4	$1K	Hold	229	–	–	﹤0.01%	6254
2019 Q3	$1K	Hold	229	–	–	﹤0.01%	6280
2019 Q2	$1K	Buy	+229	New	+$1K	﹤0.01%	6262

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo's MREO Position: Q2 2026 in Review

Wells Fargo increased its Mereo BioPharma (MREO) stake by 0.43% in Q2 2026, adding 1 share and bringing the position to 231 shares worth $73. The position accounts for ﹤0.01% of the portfolio, ranked #6679.

Wells Fargo first reported a position in MREO in Q2 2019 and has held it in 29 quarters since. The position peaked at $11K in Q1 2021. 60 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

Wells Fargo held 231 shares of Mereo BioPharma worth $73 as of Q2 2026.
Wells Fargo bought 1 Mereo BioPharma share in Q2 2026.
Mereo BioPharma made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6679 holding.
Wells Fargo first reported a position in Mereo BioPharma in Q2 2019 and has held it in 29 quarters since.
Wells Fargo's Mereo BioPharma position peaked at $11K in Q1 2021.
60 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.